Searched for
SUN PHARMA BOND ISSUANCE
New James Bond set to be named soon: Know more about the actors who are reportedly the final contenders for 007Auditions for the next James Bond actor are nearing completion as final screen tests are scheduled soon. Several actors, including Jack Low...- Sun Pharma falls short of bond fundraising target amid rising yieldsSun Pharma successfully secured ₹7,816 crore in its latest fundraising round, yet it fell short of its ambitious ₹10,000-crore target. The ...
- NSDC raises Rs 4 crore through Social Stock Exchange for global skilling initiativeThe funds raised will be used to provide skilling and employment opportunities to 600 youth from economically weaker other backward classes...
- India's JSW Paints eyes 4, 5-year debt to refinance acquisition-led funding, bankers sayIndia's JSW Paints is likely to raise funds through issuance of bonds maturing in four years and five years and should go ahead with the sa...
- Tech giants' AI spending to exceed $1 trillion in 2027, lift US growth: UBSMajor technology companies are projected to invest more than USD 1 trillion in artificial intelligence infrastructure by 2027. Reports indi...
- Bessent sees no spillover from France bond market’s turmoilScott Bessent, the US Treasury secretary, expressed that the French bond market will not affect other markets. He acknowledged the economic...
- Sun Pharma to raise Rs 10,000 crore to part-finance Organon dealSun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance b...
- India corporate bond boom may scale record in 2026 as borrowers lock in ratesIn anticipation of rising interest rates, Indian companies are poised to dramatically escalate their debt issuance activities. Many borrowe...
- Global Market: Japan bond yields fall as US tech selloff fuels safe-haven demandJapanese government bond yields fell as a selloff in US technology stocks triggered demand for safer assets. Prime Minister Sanae Takaichi’...
- Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select playersIndia's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceuti...
- Indian bonds hang tight ahead of supplyIndian government bonds remained stable on Friday as traders contemplated the central bank's forthcoming policy moves. A noteworthy auction...
- SC ruling deals a heavy blow to Yes Bank's risk equity capitalYes Bank is facing a significant reduction in its Common Equity Tier-1 capital buffer following a recent Supreme Court ruling. The court re...
- Torrent Power plans around $500 million bond sale, bankers sayTorrent Power is set to launch a substantial bond sale of rupee-denominated bonds, aiming to raise around $500 million. This comes after th...
- Global Market: Bank of China (Hong Kong) plans $3.3 billion onshore yuan debt issuanceBank of China (Hong Kong) plans to issue up to 22.2 billion yuan in onshore negotiable certificates of deposit in 2026, strengthening fundi...
- Indian debt funds set to extend $4.5 billion bond selloff after RBI policy shiftIndian mutual funds have sold $4.5 billion in government bonds since July, prompted by changing rate expectations. The Reserve Bank of Indi...
- RBI measures may boost local bond demand amid rupee pressureIndian companies may re-enter the bond market given recent central bank measures aimed at stabilizing the rupee. High overseas yields and i...
- Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-ShawBiocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push f...
- Reissued bonds account for nearly 66% of state borrowings in H1 FY27: ReportIn recent years, states have made a substantial impact on their finances by reissuing bonds, which now form a significant portion of their ...
- India bonds hemmed in as market digests higher ratesThe Reserve Bank of India has increased its key policy rate by 25 basis points, raising it to 5.50%. This adjustment signifies a strategic ...
- Sun Pharma plans $1 billion local debt sale for loan takeout, sources saySun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organo...
Load More
